United States - English - NLM (National Library of Medicine)

butler animal health supply, llc dba covetrus north america - carprofen (unii: ffl0d546ho) (carprofen - unii:ffl0d546ho) - carprofen tablets are indicated for the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs. carprofen tablets should not be used in dogs exhibiting previous hypersensitivity to carprofen.

United States - English - NLM (National Library of Medicine)

butler animal health supply, llc d/b/a henry schein animal health - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - meloxicam 5 mg in 1 ml - dogs: eloxiject™ (meloxicam) 5 mg/ml solution for injection is indicated in dogs for the control of pain and inflammation associated with osteoarthritis. dogs with known hypersensitivity to meloxicam should not receive eloxiject 5 mg/ml solution for injection. cats: for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery. cats with known hypersensitivity to meloxicam should not receive eloxiject 5 mg/ml solution for injection. additional doses of meloxicam or other nsaids in cats are contraindicated, as no safe dosage for repeated nsaid administration has been established (see animal safety). do not use meloxicam in cats with pre-existing renal dysfunction.

United States - English - NLM (National Library of Medicine)

butler animal health supply, llc dba covetrus north america - deracoxib (unii: vx29jb5xwv) (deracoxib - unii:vx29jb5xwv) - indications and usage: always provide “information for dog owners” sheet with prescription. carefully consider the potential benefits and risk of deracoxib and other treatment options before deciding to use deracoxib tablets. use the lowest effective dose for the shortest duration consistent with individual response. osteoarthritis pain and inflammation: deracoxib chewable tablets are indicated for the control of pain and inflammation associated with osteoarthritis in dogs. dosage and administration: osteoarthritis pain and inflammation: 0.45 – 0.91 mg/lb/day (1 to 2 mg/kg/ day) as a single daily dose, as needed. dogs needing a dose of less than 12.5 mg can only be accurately dosed through use of the 12 mg tablet, which can be broken in half to provide 6 mg. do not attempt to accurately dose smaller dogs through the use of breaking larger tablets. inaccurate dosing may result in adverse drug events (see adverse reactions, animal safety, and post-approval experience). postoperative orthopedic pain and inflamma

United States - English - NLM (National Library of Medicine)

butler animal health supply, llc dba covetrus north america - clindamycin hydrochloride (unii: t20oq1yn1w) (clindamycin - unii:3u02el437c) - clindamycin hydrochloride oral drops (for use in dogs and cats) is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below: skin infections (wounds and abscesses) due to coagulase positive staphylococci (staphylococcus aureus or staphylococcus intermedius ). deep wounds and abscesses due to bacteroides fragilis , prevotella melaninogenicus , fusobacterium necrophorum and clostridium perfringens . dental infections due to staphylococcus aureus , bacteroides fragilis , prevotella melaninogenicus , fusobacterium necrophorum and clostridium perfringens . osteomyelitis due to staphylococcus aureus , bacteroides fragilis , prevotella melaninogenicus , fusobacterium necrophorum and clostridium perfringens . skin infections (wounds and abscesses) due to staphylococcus aureus , staphylococcus intermedius and streptococcus spp. deep wounds and infections due to clostridium perfringens and bacteroides fragilis . dental infections due to staphylococcus aureus , staphylococcus intermedius , streptococcus spp., clostridium perfringens and bacteroides fragilis. clindamycin hydrochloride oral drops is contraindicated in animals with a history of hypersensitivity to preparations containing clindamycin or lincomycin. because of potential adverse gastrointestinal effects, do not administer to rabbits, hamsters, guinea pigs, horses, chinchillas or ruminating animals.

United States - English - NLM (National Library of Medicine)

butler animal health supply, llc dba covetrus north america - deracoxib (unii: vx29jb5xwv) (deracoxib - unii:vx29jb5xwv) - always provide “information for dog owners” sheet with prescription. carefully consider the potential benefits and risk of deracoxib chewable tablets and other treatment options before deciding to use deracoxib chewable tablets. use the lowest effective dose for the shortest duration consistent with individual response. osteoarthritis pain and inflammation: deracoxib chewable tablets are indicated for the control of pain and inflammation associated with osteoarthritis in dogs. dosage and administration: osteoarthritis pain and inflammation: 0.45 – 0.91 mg/lb/day (1 to 2 mg/kg/ day) as a single daily dose, as needed. dogs needing a dose of less than 12.5 mg can only be accurately dosed through use of the 12 mg tablet, which can be broken in half to provide 6 mg. do not attempt to accurately dose smaller dogs through the use of breaking larger tablets. inaccurate dosing may result in adverse drug events (see adverse reactions, animal safety, and post-approval experience). postoperative orthopedic pain an

United States - English - NLM (National Library of Medicine)

butler animal health supply, llc dba covetrus north america - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - cats: for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery. cats with known hypersensitivity to meloxicam should not receive meloxicam injection 5 mg/ml solution for injection. additional doses of meloxicam or other nsaids in cats are contraindicated, as no safe dosage for repeated nsaid administration has been established (see animal safety). do not use meloxicam in cats with pre-existing renal dysfunction. dogs with known hypersensitivity to meloxicam should not receive meloxicam injection 5 mg/ml solution for injection.

United States - English - NLM (National Library of Medicine)

butler animal health supply, llc dba covetrus north america - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin flavored tablets are indicated for the management of diseases associated with bacteria susceptible to enrofloxacin. enrofloxacin flavored tablets are indicated for use in dogs and cats. enrofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones. dogs: based on the studies discussed under the section on animal safety summary, the use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). the safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. large breeds may be in this phase for up to one year of age and the giant breeds for up to 18 months. in clinical field trials utilizing a daily oral dose of 5.0 mg/kg, there were no reports of lameness or joint problems in any breed. however, controlled studies with histological examination of the articular cartilage have not been conducted in the large or giant breeds.

United States - English - NLM (National Library of Medicine)

butler animal health supply, llc dba covetrus north america - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin injectable solution is indicated for the management of diseases in dogs associated with bacteria susceptible to enrofloxacin. enrofloxacin is contraindicated in dogs known to be hypersensitive to quinolones. based on the studies discussed under the section on animal safety summary, the use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). the safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. large breeds may be in this phase for up to one year of age and the giant breeds for up to 18 months. in clinical field trials utilizing a daily oral dose of 5.0 mg/kg, there were no reports of lameness or joint problems in any breed. however, controlled studies with histological examination of the articular cartilage have not been conducted in the large or giant breeds.

United States - English - NLM (National Library of Medicine)

butler animal health supply, llc dba covetrus north america - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - dogs: meloxicam injection is indicated in dogs for the control of pain and inflammation associated with osteoarthritis. dogs with known hypersensitivity to meloxicam should not receive meloxicam injection. cats: for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery. cats with known hypersensitivity to meloxicam should not receive meloxicam injection. additional doses of meloxicam or other nsaids in cats are contraindicated, as no safe dosage for repeated nsaid administration has been established (see animal safety). do not use meloxicam in cats with pre-existing renal dysfunction.

United States - English - NLM (National Library of Medicine)

butler animal health supply, llc dba covetrus north america - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - marbofloxacin chewable tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). marbofloxacin is contraindicated in cats under 12 months of age. marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.